Journal of Movement Disorders

Volume 11(3); September 2018

Review Articles

The Relationship between Saccades and Locomotion: Anshul Srivastava, Omar F. Ahmad, Christopher Pham Pacia, Mark Hallett, Codrin Lungu; J Mov Disord. 2018;11(3):93-106. Published online August 9, 2018; DOI: https://doi.org/10.14802/jmd.18018

15,524 View
506 Download
15 Web of Science
15 Crossref

Human locomotion involves a complex interplay among multiple brain regions and depends on constant feedback from the visual system. We summarize here the current understanding of the relationship among fixations, saccades, and gait as observed in studies sampling eye movements during locomotion, through a review of the literature and a synthesis of the relevant knowledge on the topic. A significant overlap in locomotor and saccadic neural circuitry exists that may support this relationship. Several animal studies have identified potential integration nodes between these overlapping circuitries. Behavioral studies that explored the relationship of saccadic and gait-related impairments in normal conditions and in various disease states are also discussed. Eye movements and locomotion share many underlying neural circuits, and further studies can leverage this interplay for diagnostic and therapeutic purposes.

Citations

Citations to this article as recorded by

Effectiveness of eye movement exercise and diaphragmatic breathing with jogging in reducing migraine symptoms: A preliminary, randomized comparison trial
Mohammad Dawood Rahimi, Pouriya Hassani, Mohammad Taghi Kheirkhah, Javad Salehi Fadardi
Brain and Behavior.2023;[Epub] CrossRef
The frequency and characteristics of saccadic dysmetria in isolated cerebellar infarction
Sohyeon Kim, Hyun Ah Kim, Hyung Lee
Neurological Sciences.2023; 44(6): 2097. CrossRef
M2 Cortex Circuitry and Sensory-Induced Behavioral Alterations in Huntington's Disease: Role of Superior Colliculus
Sara Conde-Berriozabal, Lia García-Gilabert, Esther García-García, Laia Sitjà-Roqueta, Xavier López-Gil, Emma Muñoz-Moreno, Mehdi Boutagouga Boudjadja, Guadalupe Soria, Manuel J Rodríguez, Jordi Alberch, Mercè Masana
The Journal of Neuroscience.2023; 43(18): 3379. CrossRef
The Microsoft HoloLens 2 Provides Accurate Biomechanical Measures of Performance During Military-Relevant Activities in Healthy Adults
Mandy Miller Koop, Anson B Rosenfeldt, Kelsey Owen, Eric Zimmerman, Joshua Johnston, Matthew C Streicher, Alec Albright, Amanda L Penko, Jay L Alberts
Military Medicine.2023; 188(Supplement): 92. CrossRef
What Happens in Your Brain When You Walk Down the Street? Implications of Architectural Proportions, Biophilia, and Fractal Geometry for Urban Science
Aenne A. Brielmann, Nir H. Buras, Nikos A. Salingaros, Richard P. Taylor
Urban Science.2022; 6(1): 3. CrossRef
Decreased Saccadic Eye Movement Speed Correlates with Dynamic Balance in Older Adults
Youngsook Bae
International Journal of Environmental Research and Public Health.2022; 19(13): 7842. CrossRef
Effects of different virtual reality technology driven dual-tasking paradigms on posture and saccadic eye movements in healthy older adults
Yu Imaoka, Andri Flury, Laura Hauri, Eling D. de Bruin
Scientific Reports.2022;[Epub] CrossRef
Coordination between Eye Movement and Whisking in Head-Fixed Mice Navigating a Plus Maze
Ronny Bergmann, Keisuke Sehara, Sina E. Dominiak, Jens Kremkow, Matthew E. Larkum, Robert N. S. Sachdev
eneuro.2022; 9(4): ENEURO.0089-22.2022. CrossRef
Deep brain stimulation and eye movements
Maja Klarendic, Diego Kaski
European Journal of Neuroscience.2021; 53(7): 2344. CrossRef
Antisaccade, a predictive marker for freezing of gait in Parkinson’s disease and gait/gaze network connectivity
Cécile Gallea, Benoit Wicki, Claire Ewenczyk, Sophie Rivaud-Péchoux, Lydia Yahia-Cherif, Pierre Pouget, Marie Vidailhet, Elodie Hainque
Brain.2021; 144(2): 504. CrossRef
Response Inhibition Deficits in Women with the FMR1 Premutation are Associated with Age and Fall Risk
Carly Moser, Lyndsay Schmitt, Joseph Schmidt, Amanda Fairchild, Jessica Klusek
Brain and Cognition.2021; 148: 105675. CrossRef
Concomitant improvement in anti-saccade success rate and postural instability gait difficulty after rTMS treatment for Parkinson’s disease
Ken-ichi Okada, Mizuki Takahira, Tomoo Mano, Taichi Uga, Kuni Konaka, Koichi Hosomi, Youichi Saitoh
Scientific Reports.2021;[Epub] CrossRef
Multitasking Compensatory Saccadic Training Program for Hemianopia Patients: A New Approach With 3-Dimensional Real-World Objects
Laura Mena-Garcia, Jose C. Pastor-Jimeno, Miguel J. Maldonado, Maria B. Coco-Martin, Itziar Fernandez, Juan F. Arenillas
Translational Vision Science & Technology.2021; 10(2): 3. CrossRef
The Role of Binocular Vision in Avoiding Virtual Obstacles While Walking
Jingbo Zhao, Robert S. Allison
IEEE Transactions on Visualization and Computer Graphics.2021; 27(7): 3277. CrossRef
Saccade and Fixation Eye Movements During Walking in People With Mild Traumatic Brain Injury
Ellen Lirani-Silva, Samuel Stuart, Lucy Parrington, Kody Campbell, Laurie King
Frontiers in Bioengineering and Biotechnology.2021;[Epub] CrossRef

Clinical and Imaging Features of Multiple System Atrophy: Challenges for an Early and Clinically Definitive Diagnosis: Hirohisa Watanabe, Yuichi Riku, Kazuhiro Hara, Kazuya Kawabata, Tomohiko Nakamura, Mizuki Ito, Masaaki Hirayama, Mari Yoshida, Masahisa Katsuno, Gen Sobue; J Mov Disord. 2018;11(3):107-120. Published online August 9, 2018; DOI: https://doi.org/10.14802/jmd.18020

18,436 View
1,196 Download
25 Web of Science
26 Crossref

Abstract PDF

Multiple system atrophy (MSA) is an adult-onset, progressive neurodegenerative disorder. Patients with MSA show various phenotypes during the course of their illness, including parkinsonism, cerebellar ataxia, autonomic failure, and pyramidal signs. Patients with MSA sometimes present with isolated autonomic failure or motor symptoms/ signs. The median duration from onset to the concomitant appearance of motor and autonomic symptoms is approximately 2 years but can range up to 14 years. As the presence of both motor and autonomic symptoms is essential for the current diagnostic criteria, early diagnosis is difficult when patients present with isolated autonomic failure or motor symptoms/signs. In contrast, patients with MSA may show severe autonomic failure and die before the presentation of motor symptoms/signs, which are currently required for the diagnosis of MSA. Recent studies have also revealed that patients with MSA may show nonsupporting features of MSA such as dementia, hallucinations, and vertical gaze palsy. To establish early diagnostic criteria and clinically definitive categorization for the successful development of disease-modifying therapy or symptomatic interventions for MSA, research should focus on the isolated phase and atypical symptoms to develop specific clinical, imaging, and fluid biomarkers that satisfy the requirements for objectivity, for semi- or quantitative measurements, and for uncomplicated, worldwide availability. Several novel techniques, such as automated compartmentalization of the brain into multiple parcels for the quantification of gray and white matter volumes on an individual basis and the visualization of α-synuclein and other candidate serum and cerebrospinal fluid biomarkers, may be promising for the early and clinically definitive diagnosis of MSA.

Citations

Citations to this article as recorded by

Cranial Nerve Thinning Distinguishes RFC1‐Related Disorder from Other Late‐Onset Ataxias
Camila C. Lobo, Guilherme S.O. Wertheimer, Gabriel S. Schmitt, Paula C.A.A.P. Matos, Thiago J.R. Rezende, Joyce M. Silva, Fabrício C. Borba, Fabrício D. Lima, Alberto R.M. Martinez, Orlando G.P. Barsottini, José Luiz Pedroso, Wilson Marques, Marcondes C.
Movement Disorders Clinical Practice.2024; 11(1): 45. CrossRef
The potential of phosphorylated α‐synuclein as a biomarker for the diagnosis and monitoring of multiple system atrophy
Toufik Abdul‐Rahman, Ranferi Eduardo Herrera‐Calderón, Arjun Ahluwalia, Andrew Awuah Wireko, Tomas Ferreira, Joecelyn Kirani Tan, Maximillian Wolfson, Shankhaneel Ghosh, Viktoriia Horbas, Vandana Garg, Asma Perveen, Marios Papadakis, Ghulam Md Ashraf, Ath
CNS Neuroscience & Therapeutics.2024;[Epub] CrossRef
The effect of continuous positive airway pressure (CPAP) on the quality of life in patients with multiple system atrophy
Hee Jin Chang, Han-Joon Kim, Kyung Ah Woo, Jung Hwan Shin, Ki-Young Jung
Sleep and Breathing.2023; 27(4): 1481. CrossRef
Psychosis treatment in a patient with Parkinsonian type multiple system atrophy using modified electroconvulsive therapy: a case report
Takumi Yawata, Shunsuke Takagi, Takehiro Tamura, Genichi Sugihara, Hidehiko Takahashi
Psychogeriatrics.2023; 23(2): 364. CrossRef
Comparison of the second consensus statement with the movement disorder society criteria for multiple system atrophy: A single-center analysis
Yunchuang Sun, Wei Sun, Luhua Wei, Fan Li, Yanyan Jiang, Fei Zhai, Mingyue Luan, Jing Chen, Zhaoxia Wang
Parkinsonism & Related Disorders.2023; 106: 105242. CrossRef
Multiple System Atrophy: Advances in Diagnosis and Therapy
Hirohisa Watanabe, Sayuri Shima, Yasuaki Mizutani, Akihiro Ueda, Mizuki Ito
Journal of Movement Disorders.2023; 16(1): 13. CrossRef
Multiple system atrophy-cerebellar: A case report and literature review
Thi Thuong Doan, Thuy Dung Pham, Duy Duan Nguyen, Dac Hong An Ngo, Trong Binh Le, Thanh Thao Nguyen
Radiology Case Reports.2023; 18(3): 1121. CrossRef
Hjerne med kors
Linh Tran, Tuba Ahmad, Anniken Haslund, Phuoc Ngoc Thi Nguyen
Tidsskrift for Den norske legeforening.2023;[Epub] CrossRef
α-Synuclein Strains and Their Relevance to Parkinson’s Disease, Multiple System Atrophy, and Dementia with Lewy Bodies
Noah J. Graves, Yann Gambin, Emma Sierecki
International Journal of Molecular Sciences.2023; 24(15): 12134. CrossRef
A Rare Case of Cerebellar Ataxia
Aanchal Arora, Nidhi Hooda, JasneetSingh Channa, Motilal Negi
Neurology India.2023; 71(5): 1031. CrossRef
Neurodegenerative disorders affecting the autonomic nervous system: Pure autonomic failure and multiple system atrophy
Yoshitaka Yamanaka, Nobuyuki Araki, Satoshi Kuwabara
Neurology and Clinical Neuroscience.2022; 10(3): 115. CrossRef
Glia Imaging Differentiates Multiple System Atrophy from Parkinson's Disease: A Positron Emission Tomography Study with [11C]PBR28 and Machine Learning Analysis
Aurelija Jucaite, Zsolt Cselényi, William C. Kreisl, Eugenii A. Rabiner, Andrea Varrone, Richard E. Carson, Juha O. Rinne, Alicia Savage, Magnus Schou, Peter Johnström, Per Svenningsson, Olivier Rascol, Wassilios G. Meissner, Paolo Barone, Klaus Seppi, Ho
Movement Disorders.2022; 37(1): 119. CrossRef
Data-driven subtype classification of patients with early-stage multiple system atrophy
Hui-Jun Yang, Han-Joon Kim, Yu Jin Jung, Dallah Yoo, Ji-Hyun Choi, Jin Hee Im, Beomseok Jeon
Parkinsonism & Related Disorders.2022; 95: 92. CrossRef
Clinicopathological correlates of pyramidal signs in multiple system atrophy
Chi‐Ying R. Lin, Anisha Viswanathan, Tiffany X. Chen, Hiroshi Mitsumoto, Jean P. Vonsattel, Phyllis L. Faust, Sheng‐Han Kuo
Annals of Clinical and Translational Neurology.2022; 9(7): 988. CrossRef
The “Black Straight-Line Sign” in the Putamen in Diffusion-Weighted Imaging: A Potential Diagnostic MRI Marker for Multiple System Atrophy
Yiming Zheng, Xiwen Wang, Huajian Zhao, Yanyan Jiang, Ying Zhu, Jing Chen, Wei Sun, Zhaoxia Wang, Yunchuang Sun
Frontiers in Neurology.2022;[Epub] CrossRef
Clinical Aspects of the Differential Diagnosis of Parkinson’s Disease and Parkinsonism
Hae-Won Shin, Sang-Wook Hong, Young Chul Youn
Journal of Clinical Neurology.2022; 18(3): 259. CrossRef
Clinical Features and Neuroimaging Findings of Neuropil Antibody–Positive Idiopathic Sporadic Ataxia of Unknown Etiology
Akira Takekoshi, Akio Kimura, Nobuaki Yoshikura, Isamu Yamakawa, Makoto Urushitani, Katsuya Nakamura, Kunihiro Yoshida, Takayoshi Shimohata
The Cerebellum.2022; 22(5): 915. CrossRef
Determinants of cognitive impairment in multiple system atrophy: Clinical and genetic study
Amina Nasri, Alya Gharbi, Ikram Sghaier, Saloua Mrabet, Amira Souissi, Amina Gargouri, Mouna Ben Djebara, Imen Kacem, Riadh Gouider, Tuhin Virmani
PLOS ONE.2022; 17(12): e0277798. CrossRef
Management of balance problems in an elderly with multiple system atrophy with predominant cerebellar ataxia (MSA-C) and sick sinus syndrome
Amber Eker, Pembe Hare Yıgıtoglu, Hamza Duygu, Ersin Tan
Journal of Gerontology and Geriatrics.2021; 69(3): 208. CrossRef
Immunotherapies in Huntington's disease and α-Synucleinopathies
Oluwaseun Fatoba, Yosuke Ohtake, Takahide Itokazu, Toshihide Yamashita
Frontiers in Immunology.2020;[Epub] CrossRef
The Dysfunctional Autonomic Function and “Dysfunctional” Fatigue in Drug Naïve Parkinson’s Disease
Jong Hyeon Ahn, Minkyeong Kim, Jun Kyu Mun, Yoonsu Cho, Ji Sun Kim, Jinyoung Youn, Joong-Seok Kim, Jin Whan Cho
Journal of Parkinson's Disease.2020; 10(2): 605. CrossRef
Early autonomic and cognitive dysfunction in PD, DLB and MSA: blurring the boundaries between α-synucleinopathies
Giovanni Palermo, Eleonora Del Prete, Ubaldo Bonuccelli, Roberto Ceravolo
Journal of Neurology.2020; 267(12): 3444. CrossRef
Changes of Amide Proton Transfer Imaging in Multiple System Atrophy Parkinsonism Type
Shuhua Li, Piu Chan, Chunmei Li, Haibo Chen, Min Chen, Wen Su, Kai Li, Na Lu, Lu Yu, Defa Chu, Pu-Yeh Wu
Frontiers in Aging Neuroscience.2020;[Epub] CrossRef
Frontline of Non-genetic Cerebellar Ataxia
Nobuaki Yoshikura, Akio Kimura, Takayoshi Shimohata
Nihon Naika Gakkai Zasshi.2020; 109(6): 1138. CrossRef
Purva Rupeeyam of bhela indriya sthana-an explorative study
Kshama Gupta, Prasad Mamidi
International Journal of Complementary & Alternative Medicine.2020; 13(6): 228. CrossRef
A case of multiple system atrophy
Jing Guo, Fuying Liu, Tingting Liu, Xin Zhang, Yong Luo
Journal of International Medical Research.2019; 47(11): 5839. CrossRef

Original Articles

Individual Therapeutic Singing Program for Vocal Quality and Depression in Parkinson’s Disease: Eun Young Han, Ji Young Yun, Hyun Ju Chong, Kyoung-Gyu Choi; J Mov Disord. 2018;11(3):121-128. Published online August 9, 2018; DOI: https://doi.org/10.14802/jmd.17078

12,742 View
295 Download
14 Web of Science
10 Crossref

Abstract PDF Supplementary Material

Objective
Patients with Parkinson’s disease (PD) frequently experience depression associated with voice problems. Singing involves the use of similar muscles and the neural networks associated with vocal function and emotional response. The purpose of this study is to enhance vocal quality and depressive symptoms of patients with PD using individual singing program.
Methods
The Individual Therapeutic Singing Program for PD (ITSP-PD) was conducted by a certified music therapist. In total, nine PD patients with a subjective voice problem or depression participated in 6 sessions over 2 weeks. We measured the Maximum Phonation Time (MPT) via the Praat test, the Voice Handicap Index (VHI), the Voice-Related Quality of Life (V-RQOL) and the Geriatric Depression Scale (GDS).
Results
In total, 8 out of 9 patients completed all the sessions; 6 out of 8 patients participated in the follow-up test after 6 months. A statistically significant change in MPT (p = 0.011) was observed between the pre- and post-tests. The VHI (p = 0.035) and the GDS (p = 0.018) were significantly lower in the post-test. In the pre-, post-, and follow-up tests, the MPT (p = 0.030), V-RQOL (p = 0.008), and GDS (p = 0.009) were significantly changed.
Conclusion
The ITSP-PD based on neurological singing therapy for PD showed therapeutic possibility for vocal function and depression in patients with PD. Our findings suggest the need for a randomized study to examine the continuing positive effects of the ITSP-PD over a longer period of time.

Citations

Citations to this article as recorded by

Functional data analysis of prosodic prominence in Parkinson’s disease: a pilot study
Lauri Tavi, Nelly Penttilä
Clinical Linguistics & Phonetics.2024; 38(1): 64. CrossRef
Awareness of Dysphagia-Related Complications and Risks and the Importance of Early Intervention in Patients with Parkinson’s Disease: A Qualitative Study
Kaifeng Yao, Lihua Wang, Lihua Zhang, Aderito Seixas
International Journal of Clinical Practice.2023; 2023: 1. CrossRef
Group singing improves both physical and psychological wellbeing in people with and without chronic health conditions: A narrative review
Quinn Campbell, Sally Bodkin-Allen, Nicola Swain
Journal of Health Psychology.2022; 27(8): 1897. CrossRef
Defining the Therapeutic Singing Voice: Further Examination of the Everyday Singing Practices of Music Therapists
Martina C Bingham, Elizabeth K Schwartz, Anthony Meadows
Music Therapy Perspectives.2022; 40(1): 3. CrossRef
Music affects functional brain connectivity and is effective in the treatment of neurological disorders
Luisa Speranza, Salvatore Pulcrano, Carla Perrone-Capano, Umberto di Porzio, Floriana Volpicelli
Reviews in the Neurosciences.2022; 33(7): 789. CrossRef
Acute effects of singing on cardiovascular biomarkers
Kamila Somayaji, Mogen Frenkel, Luai Tabaza, Alexis Visotcky, Tanya Kruse Ruck, Ernest Kwesi Ofori, Michael E. Widlansky, Jacquelyn Kulinski
Frontiers in Cardiovascular Medicine.2022;[Epub] CrossRef
Music Therapy and Parkinson’s Disease: A Systematic Review from 2015–2020
Manuel Joaquín Machado Sotomayor, Víctor Arufe-Giráldez, Gerardo Ruíz-Rico, Rubén Navarro-Patón
International Journal of Environmental Research and Public Health.2021; 18(21): 11618. CrossRef
The use of music as an arts-based method in migrant health research: a scoping review protocol
Fran Garry, Sylvia Murphy Tighe, Anne MacFarlane, Helen Phelan
HRB Open Research.2020; 3: 75. CrossRef
Walking the thin white line – managing voice in the older adult
Jacqui Allen, Anna Miles
Speech, Language and Hearing.2019; 22(1): 25. CrossRef
Music Therapy and Music-Based Interventions for Movement Disorders
Kerry Devlin, Jumana T. Alshaikh, Alexander Pantelyat
Current Neurology and Neuroscience Reports.2019;[Epub] CrossRef

Transfer Dysphagia Due to Focal Dystonia: Priyanka Samal, Vinay Goyal, Govind K Makharia, Chandan J Das, Sankar Prasad Gorthi, Vishnu V Y, Mamta Bhushan Singh, M V Padma Srivastava; J Mov Disord. 2018;11(3):129-132. Published online September 30, 2018; DOI: https://doi.org/10.14802/jmd.17081

7,260 View
125 Download
1 Web of Science
2 Crossref

Abstract PDF Supplementary Material

Objective
The inability to propel a bolus of food successfully from the posterior part of the oral cavity to the oropharynx is defined as transfer dysphagia. The present case series describes the varied presentation of transfer dysphagia due to focal dystonia and highlights the importance of early detection by following up on strong suspicions.
Methods
We describe seven cases of transfer dysphagia due to focal dystonia. Transfer dysphagia as a form of focal dystonia may appear as the sole presenting complaint or may present with other forms of focal dystonia.
Results
Four out of seven patients had pure transfer dysphagia and had previously been treated for functional dysphagia. A high index of suspicion, barium swallow including videofluoroscopy, associated dystonia in other parts of the body and response to drug therapy with trihexyphenidyl/tetrabenazine helped to confirm the diagnosis.
Conclusion
Awareness of these clinical presentations among neurologists and non-neurologists can facilitate an early diagnosis and prevent unnecessary investigations.

Citations

Citations to this article as recorded by

EXCESSIVE CRYING IN CHILDREN WITH CEREBRAL PALSY AND COMMUNICATION DEFICITS
Nagabhushana Rao Potharaju
GLOBAL JOURNAL FOR RESEARCH ANALYSIS.2022; : 25. CrossRef
Oro-Pharyngeal Dysphagia in Parkinson’s Disease and Related Movement Disorders
Miseon Kwon, Jae-Hong Lee
Journal of Movement Disorders.2019; 12(3): 152. CrossRef

Musculoskeletal Problems Affect the Quality of Life of Patients with Parkinson’s Disease: Young Eun Kim, Han-Joon Kim, Ji Young Yun, Woong-Woo Lee, Hui-Jun Yang, Jong-Min Kim, Beomseok Jeon; J Mov Disord. 2018;11(3):133-138. Published online September 30, 2018; DOI: https://doi.org/10.14802/jmd.18022

8,125 View
148 Download
11 Web of Science
9 Crossref

Abstract PDF

Objective
Musculoskeletal problems are more common in patients with Parkinson’s disease (PD) than in normal elderly, but the impact of musculoskeletal problems on health-related quality of life (HRQoL) in patients with PD is unknown.
Methods
Four hundred consecutive patients with PD were enrolled for the evaluation of musculoskeletal problems and HRQoL. HRQoL was assessed by the 36-Item Short Form Health Survey, which comprised physical health and mental health.
Results
Of the total patients, 265 patients had musculoskeletal problems, and 135 patients did not have musculoskeletal problems. Patients with musculoskeletal problems reported lower levels of HRQoL in terms of physical health than did patients without musculoskeletal problems (p < 0.05). In women, all components of physical health were lower in patients with musculoskeletal problems than in patients without musculoskeletal problems (p < 0.05). Meanwhile, in men, only the bodily pain score of physical health was lower in patients with musculoskeletal problems than in patients without musculoskeletal problems. Mental health and physical health were negatively correlated with depression, Unified Parkinson’s Disease Rating Scale I & II scores, and pain severity from musculoskeletal problems, in that order (p < 0.01 for all).
Conclusion
These results suggest that musculoskeletal problems in patients with PD affect HRQoL significantly, mainly in terms of physical health rather than mental health and especially in women rather than men. Musculoskeletal problems should not be overlooked in the care of patients with PD.

Citations

Citations to this article as recorded by

Total knee arthroplasty in patients with Parkinson’s disease: A systematic review and meta-analysis protocol
Guangchen Sun, Hui Yu, Jun Cui, Ming Li, Yuefang Ru
Medicine.2022; 101(52): e32315. CrossRef
Quality of life of older adults in two contrasting neighbourhoods in Accra, Ghana
Dominic A. Alaazi, Devidas Menon, Tania Stafinski, Stephen Hodgins, Gian Jhangri
Social Science & Medicine.2021; 270: 113659. CrossRef
The Efficiency of Spa Rehabilitation in Chronic Ischemic Stroke Patients—Preliminary Reports
Bogumiła Pniak, Justyna Leszczak, Jadwiga Kurczab, Aleksandra Krzemińska, Joanna Pięta, Agnieszka Plis, Ewelina Czenczek-Lewandowska, Agnieszka Guzik
Brain Sciences.2021; 11(4): 501. CrossRef
Sex-specific effects of subthalamic nucleus stimulation on pain in Parkinson’s disease
Olga Khazen, Marisa DiMarzio, Kelsey Platanitis, Heather C. Grimaudo, Maria Hancu, Miriam M. Shao, Michael D. Staudt, Lucy Maguire, Vishad V. Sukul, Jennifer Durphy, Era K. Hanspal, Octavian Adam, Eric Molho, Julie G. Pilitsis
Journal of Neurosurgery.2021; 135(2): 629. CrossRef
An overview of pain in Parkinson's disease
Yi-Cheng Tai, Chin-Hsien Lin
Clinical Parkinsonism & Related Disorders.2020; 2: 1. CrossRef
Clinical Perspectives of Parkinson's Disease for Ophthalmologists, Otorhinolaryngologists, Cardiologists, Dentists, Gastroenterologists, Urologists, Physiatrists, and Psychiatrists
Ji-Hyun Choi, Jong-Min Kim, Hee Kyung Yang, Hyo-Jung Lee, Cheol Min Shin, Seong Jin Jeong, Won-Seok Kim, Ji Won Han, In-Young Yoon, Yoo Sung Song, Yun Jung Bae
Journal of Korean Medical Science.2020;[Epub] CrossRef
Parkinson's Disease Is Associated with Increased Complications, Readmission Rates, and Costs of Care after Total Hip Arthroplasty: A Matched-Cohort Analysis
Simon Katz, Kevin B. Marchand, Rushabh M. Vakharia, Hiba Anis, Nipun Sodhi, Nicolas S. Piuzzi, Michael A. Mont, Martin W. Roche
The Journal of Hip Surgery.2020; 4(03): 149. CrossRef
Chronic Pain Treatment Strategies in Parkinson’s Disease
Amber Edinoff, Niro Sathivadivel, Timothy McBride, Allyson Parker, Chikezie Okeagu, Alan D. Kaye, Adam M. Kaye, Jessica S. Kaye, Rachel J. Kaye, Meeta M. Sheth, Omar Viswanath, Ivan Urits
Neurology International.2020; 12(3): 61. CrossRef
Sex differences in the short-term and long-term effects of subthalamic nucleus stimulation in Parkinson's disease
Ryul Kim, Dallah Yoo, Ji-Hyun Choi, Jung Hwan Shin, Sangmin Park, Han-Joon Kim, Sun Ha Paek, Beomseok Jeon
Parkinsonism & Related Disorders.2019; 68: 73. CrossRef

Cognition, Olfaction and Uric Acid in Early de novo Parkinson’s Disease: Hwa Reung Lee, Joong Hyun Park, Sang Won Han, Jong Sam Baik; J Mov Disord. 2018;11(3):139-144. Published online September 30, 2018; DOI: https://doi.org/10.14802/jmd.18037

6,736 View
149 Download
7 Web of Science
6 Crossref

Abstract PDF

Objective
Cognitive impairment is one of the nonmotor symptoms in Parkinson’s disease (PD), and olfactory dysfunction is used as a marker to detect premotor stages of PD. Serum uric acid (sUA) levels have been found to be a risk factor for PD. Our objective in this study was to examine whether sUA levels are associated with cognitive changes and olfactory dysfunction in early de novo PD patients.
Methods
The study participants included 196 de novo PD patients. We assessed cognitive function by the Korean versions of the Mini-Mental State Examination and the Montreal Cognitive Assessment and assessed olfactory function by the Korean version of the Sniffin’ Sticks test.
Results
The mean sUA level was 4.7 mg/dL and was significantly lower in women than in men. Cognitive scores were lower in women, suggesting that sUA levels were related to cognitive function. The olfactory functions were not related to sUA level but were clearly associated with cognitive scores. Olfactory threshold, odor discrimination, and odor identification were all significantly related to cognitive scores.
Conclusion
We conclude that lower sUA levels were associated with cognitive impairment, not olfactory dysfunction, in de novo PD patients. This finding suggests that UA is neuroprotective as an antioxidant in the cognitive function of PD patients.

Citations

Citations to this article as recorded by

Serum uric acid and Parkinson's disease: A systematic review and meta‐analysis
Mohammad Balabandian, Sarvenaz Salahi, Behnaz Mahmoudvand, Mahla Esmaeilzadeh, Seyedeh Melika Hashemi, Fardin Nabizadeh
Neurology and Clinical Neuroscience.2023; 11(6): 299. CrossRef
International consensus statement on allergy and rhinology: Olfaction
Zara M. Patel, Eric H. Holbrook, Justin H. Turner, Nithin D. Adappa, Mark W. Albers, Aytug Altundag, Simone Appenzeller, Richard M. Costanzo, Ilona Croy, Greg E. Davis, Puya Dehgani‐Mobaraki, Richard L. Doty, Valerie B. Duffy, Bradley J. Goldstein, David
International Forum of Allergy & Rhinology.2022; 12(4): 327. CrossRef
Association of serum uric acid and non-motor symptoms in Parkinson's disease: A cross-sectional study from a movement disorders clinic in Lagos, Nigeria
OlanikeA Odeniyi, OluwadamilolaO Ojo, IfedayoAdeola Odeniyi, NjidekaUlunma Okubadejo
Journal of Clinical Sciences.2022; 19(3): 104. CrossRef
A postmortem study suggests a revision of the dual-hit hypothesis of Parkinson’s disease
Per Borghammer, Mie Kristine Just, Jacob Horsager, Casper Skjærbæk, Anna Raunio, Eloise H. Kok, Sara Savola, Shigeo Murayama, Yuko Saito, Liisa Myllykangas, Nathalie Van Den Berge
npj Parkinson's Disease.2022;[Epub] CrossRef
What substance P might tell us about the prognosis and mechanism of Parkinson's disease?
Paola Tirassa, Tommaso Schirinzi, Marcello Raspa, Massimo Ralli, Antonio Greco, Antonella Polimeni, Roberta Possenti, Nicola Biagio Mercuri, Cinzia Severini
Neuroscience & Biobehavioral Reviews.2021; 131: 899. CrossRef
Brain-First versus Gut-First Parkinson’s Disease: A Hypothesis
Per Borghammer, Nathalie Van Den Berge, Teus van Laar
Journal of Parkinson's Disease.2019; 9(s2): S281. CrossRef

Case Report

A Patient with Myotonic Dystrophy Type 1 Presenting as Parkinsonism: Ji-Hyun Choi, Jee-Young Lee, Han-Joon Kim, Beomseok Jeon; J Mov Disord. 2018;11(3):145-148. Published online September 30, 2018; DOI: https://doi.org/10.14802/jmd.18028

5,761 View
103 Download
1 Web of Science

Abstract PDF: The current body of literature contains 5 reports of myotonic dystrophy (DM) with parkinsonism: 4 reports of DM type 2 and 1 report of clinically suspected DM type 1. To date, there have been no genetically proven cases of DM type 1 with parkinsonism. Here, we report the first case of genetically proven DM type 1 and parkinsonism that developed ahead of muscle symptoms with bilateral putaminal, presynaptic dopaminergic deficits on imaging. A 54-year-old female patient presented with bradykinesia, axial and bilateral limb rigidity, stooped posture, and hypomimia, which did not respond to levodopa. At age 56, she developed neck flexion weakness. Examination showed bilateral facial weakness, percussion and grip myotonia, and electromyography confirmed myotonic discharges. A genetic study of DM type 1 showed a DMPK mutation. At age 58, gait freezing, postural instability, and frequent falling developed and did not respond to increasing doses of levodopa. At age 59, the patient died from asphyxia.

Letter to the editor

Chorea in Sporadic Creutzfeldt-Jakob Disease: Ai Huey Tan, Tsun Haw Toh, Soon Chai Low, Si Lei Fong, Kah Kian Chong, Kee Wei Lee, Khean Jin Goh, Shen-Yang Lim; J Mov Disord. 2018;11(3):149-151. Published online August 9, 2018; DOI: https://doi.org/10.14802/jmd.18017

6,004 View
148 Download
2 Web of Science
3 Crossref

PDF Supplementary Material

Citations

Citations to this article as recorded by

Atypical and early symptoms of sporadic Creutzfeldt – Jakob disease: case series and review of the literature
Grammatiki Katsikaki, Ioannis E. Dagklis, Petros Angelopoulos, Dimitrios Ntantos, Angeliki Prevezianou, Sevasti Bostantjopoulou
International Journal of Neuroscience.2021; 131(9): 927. CrossRef
Review of Hereditary and Acquired Rare Choreas
Daniel Martinez-Ramirez, Ruth H. Walker, Mayela Rodríguez-Violante, Emilia M. Gatto
Tremor and Other Hyperkinetic Movements.2020;[Epub] CrossRef
A Case of Creutzfeldt-Jakob Disease Presented as Rapid Progressive Parkinsonism
Yoonah Park, Chan-Nyeong Lee
Dementia and Neurocognitive Disorders.2019; 18(4): 152. CrossRef

First
Prev
Page of 1
Next
Last

Previous issues